Search Results - "Barbon, Elena"

Refine Results
  1. 1
  2. 2

    Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function by Tajnik, Mojca, Rogalska, Malgorzata Ewa, Bussani, Erica, Barbon, Elena, Balestra, Dario, Pinotti, Mirko, Pagani, Franco

    Published in PLoS genetics (26-05-2016)
    “…Mutations that result in amino acid changes can affect both pre-mRNA splicing and protein function. Understanding the combined effect is essential for correct…”
    Get full text
    Journal Article
  3. 3

    In vivo liver targeted genome editing as therapeutic approach: progresses and challenges by Simoni, Chiara, Barbon, Elena, Muro, Andrés F, Cantore, Alessio

    Published in Frontiers in genome editing (2024)
    “…The liver is an essential organ of the body that performs several vital functions, including the metabolism of biomolecules, foreign substances, and toxins,…”
    Get full text
    Journal Article
  4. 4

    Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts by Pignani, Silvia, Zappaterra, Federico, Barbon, Elena, Follenzi, Antonia, Bovolenta, Matteo, Bernardi, Francesco, Branchini, Alessio, Pinotti, Mirko

    “…Engineered transcription factors (TF) have expanded our ability to modulate gene expression and hold great promise as bio-therapeutics. The first-generation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System by Lattanzi, Annalisa, Duguez, Stephanie, Moiani, Arianna, Izmiryan, Araksya, Barbon, Elena, Martin, Samia, Mamchaoui, Kamel, Mouly, Vincent, Bernardi, Francesco, Mavilio, Fulvio, Bovolenta, Matteo

    Published in Molecular therapy. Nucleic acids (16-06-2017)
    “…Exonic duplications account for 10%–15% of all mutations in Duchenne muscular dystrophy (DMD), a severe hereditary neuromuscular disorder. We report a CRISPR…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice by Lisjak, Michela, De Caneva, Alessia, Marais, Thibaut, Barbon, Elena, Biferi, Maria Grazia, Porro, Fabiola, Barzel, Adi, Zentilin, Lorena, Kay, Mark A, Mingozzi, Federico, Muro, Andrés F

    Published in Frontiers in genome editing (11-03-2022)
    “…Many inborn errors of metabolism require life-long treatments and, in severe conditions involving the liver, organ transplantation remains the only curative…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics by Barbon, Elena, Ferrarese, Mattia, van Wittenberghe, Laetitia, Sanatine, Peggy, Ronzitti, Giuseppe, Collaud, Fanny, Colella, Pasqualina, Pinotti, Mirko, Mingozzi, Federico

    Published in Molecular therapy. Nucleic acids (29-11-2016)
    “…Disease-causing splicing mutations can be rescued by variants of the U1 small nuclear RNA (U1snRNAs). However, the evaluation of the efficacy and safety of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor by Barbon, Elena, Kawecki, Charlotte, Marmier, Solenne, Sakkal, Aboud, Collaud, Fanny, Charles, Severine, Ronzitti, Giuseppe, Casari, Caterina, Christophe, Olivier, Denis, Cécile, Lenting, Peter J., Mingozzi, Federico

    Published in Gene therapy (01-04-2023)
    “…Abstract Von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is caused by quantitative or qualitative defects in von…”
    Get full text
    Journal Article
  13. 13

    Regulation of a strong F9 cryptic 5′ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides by Balestra, Dario, Barbon, Elena, Scalet, Daniela, Cavallari, Nicola, Perrone, Daniela, Zanibellato, Silvia, Bernardi, Francesco, Pinotti, Mirko

    Published in Human molecular genetics (01-09-2015)
    “…Mutations affecting specific splicing regulatory elements offer suitable models to better understand their interplay and to devise therapeutic strategies. Here…”
    Get full text
    Journal Article
  14. 14

    Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides by Balestra, Dario, Barbon, Elena, Scalet, Daniela, Cavallari, Nicola, Perrone, Daniela, Zanibellato, Silvia, Bernardi, Francesco, Pinotti, Mirko

    Published in Human molecular genetics (01-09-2015)
    “…Mutations affecting specific splicing regulatory elements offer suitable models to better understand their interplay and to devise therapeutic strategies. Here…”
    Get full text
    Journal Article
  15. 15

    Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor by Barbon, Elena, Kawecki, Charlotte, Marmier, Solenne, Sakkal, Aboud, Collaud, Fanny, Charles, Severine, Ronzitti, Giuseppe, Casari, Caterina, Christophe, Olivier D., Denis, Cécile V., Lenting, Peter J., Mingozzi, Federico

    Published in Gene therapy (01-04-2023)
    “…Von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is caused by quantitative or qualitative defects in von Willebrand factor…”
    Get full text
    Journal Article
  16. 16

    Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model by Donadon, Irving, Pinotti, Mirko, Rajkowska, Katarzyna, Pianigiani, Giulia, Barbon, Elena, Morini, Elisabetta, Motaln, Helena, Rogelj, Boris, Mingozzi, Federico, Slaugenhaupt, Susan A, Pagani, Franco

    Published in Human molecular genetics (15-07-2018)
    “…Abstract Familial dysautonomia (FD) is a rare genetic disease with no treatment, caused by an intronic point mutation (c.2204+6T>C) that negatively affects the…”
    Get full text
    Journal Article
  17. 17

    An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes by Barbon, Elena, Pignani, Silvia, Branchini, Alessio, Bernardi, Francesco, Pinotti, Mirko, Bovolenta, Matteo

    Published in Scientific reports (24-06-2016)
    “…Tailored approaches to restore defective transcription responsible for severe diseases have been poorly explored. We tested transcription activator-like…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20